hSIRPA(2)/hCD47/hPD-L1
Nomenclature
C57BL/6Smoc-Sirpatm2(hSIRPA)Cd274tm1(hCD274)Cd47tm1(hCD47)Smoc
Cat. NO.
NM-HU-2000095
Strain State
Embryo cryopreservation
Model Description
hPD-L1(NM-HU-00062),hCD47(NM-HU-00050) was crossed with hSIRPA(2) (NM-HU-18015) to generate hSIRPA(2)/hCD47/hPD-L1.
Research Application：Immunotherapy,cancer research,drug screening
*Literature published using this strain should indicate: hSIRPA(2)/hCD47/hPD-L1 mice (Cat. NO. NM-HU-2000095) were purchased from Shanghai Model Organisms Center, Inc..
You may also like
Shanghai Model Organisms Center Inc has licensed CRISPR-Cas9 technology from Broad Institute
On Dec 16, 2018, Broad Institute and Shanghai Model Organisms Center Inc (SMOC) has entered into a non-exclusive license agreement under which Broad has granted SMOC worldwide rights to commercialize a service platform for genetically modified mouse models under Broad's intellectual property.
Learn more
Workshop：Progress and Advances in Preclinical immuno-Oncology Research
SMOC’s Annual Progress and Advances in Preclinical immuno-Oncology Research: The workshop is designed as a forum for ideas and opinions exchange on how to decrease the rate of clinical failures in oncology and immuno-oncology.
Learn more
